Pasar al contenido principal

ESTUDIO DE LAS BASES MOLECULARES DE LA INESTABILIDAD GENOMICA ASOCIADA A LAS TOPOISOMERASAS DE DNA

PID2022-137143NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

EWS::FLI1-DHX9 interaction promotes Ewing sarcoma sensitivity to DNA topoisomerase 1 poisons by altering R-loop metabolism

  • Olmedo-Pelayo, Joaquín
  • Granado-Calle, Esperanza
  • Delgado-Bellido, Daniel
  • Lobo Selma, Laura
  • Jordán-Pérez, Carmen
  • Monteiro-Amaral, Ana T.
  • Ehlers, Anna C.
  • Ohmura, Shunya
  • García-Domínguez, Daniel
  • Mackintosh, Carlos
  • Carcaboso, Ángel M.
  • Alonso García de la Rosa, Francisco Javier
  • Machado, Isidro
  • Llombart-Bosch, A.
  • Scotlandi, Katia
  • Grünewald, Thomas G. P.
  • Gómez-Herreros, Fernando
  • Álava, Enrique de
Drug resistance is an ill-defined cause of dismal outcomes in cancer. Ewing sarcoma (EwS), a pediatric cancer characterized by high therapy failure rates, is driven by a single oncogenic event generating EWSR1::ETS gene fusions (primarily EWSR1::FLI1) in a silent genomic background. This provides a straightforward model to study the impact of gene fusions on drug responses. Here, we describe a novel mechanism of sensitivity to DNA topoisomerase 1 poisons in EwS. We discovered that EWS::FLI1 prevents the resolution of R-loops induced by these drugs via sequestering DHX9 helicase, ultimately resulting in R-loop accumulation, replication stress, and genome instability. In turn, excessive DHX9 or reduced EWS::FLI1 levels render EwS cells resistant to the active metabolite of irinotecan (SN-38) independent of proliferation and global transcription rates. This resistance helps explain how elevated DHX9 levels predict worse clinical outcomes. Overall, our research demonstrates the impact of a dominant mutation on cancer drug sensitivity, highlighting its significant clinical implications., JO-P is supported by Ph.D. grant Plan Propio from the University of Seville. DD-B is supported by Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (PAIDI 2020, POSTDOC_21_00865). DJG-D was supported by the VII Plan Propio de Investigación y Transferencia de la Universidad de Sevilla [Contrato de Acceso (II.4)/VII PPIT-US]. The laboratory of JA is supported by Instituto de Salud Carlos III (grant numbers PI20CIII/00020, DTS22CIII/00003, PMP21-00073); Asociación Pablo Ugarte (TRPV205/18, DGDO195722); Asociación Candela Riera, Asociación Todos Somos Iván & Fundación Sonrisa de Alex (TVP333-19, TVP-1324/15). The laboratory of TGPG is supported by grants from the Matthias-Lackas Foundation, the Dr. Leopold und Carmen Ellinger Foundation, the Deutsche Forschungsgemeinschaft (DFG 458891500), the German Cancer Aid (DKH-7011411, DKH-70114278), the Boehringer-Ingelheim foundation, the Dr. Rolf M. Schwiete foundation, the SMARCB1 association, the Ministry of Education and Research (BMBF; SMART-CARE and HEROES-AYA) and the Barbara and Wilfried Mohr foundation. A.C.E. was supported by a scholarship from the German Cancer Aid. The laboratory of FG-H is supported by grants funded by MCIN/AEI/10.13039/501100011033/FEDER, UE (R + D + i PID2019-105212GB-I00 and PID2022-137143NB-I00) and the Andalusian Regional Government: Fondo Europeo de Desarrollo Regional (FEDER) y Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía (P20_00561) to FG-H. The laboratory of EdA is supported by grants from ISCIII-FEDER (PI20/00003, PI23/1460 and PMP22/00054), Consejería de Salud y Consumo, Junta de Andalucía (PE-0186-2018, PI-0061-2020), Fundación Científica AECC (ECAEC222952DEAL), Fundación CRIS Contra el Cáncer, Asociación Pablo Ugarte, Fundación María García Estrada, and CIBERONC Instituto de Salud Carlos III, CB16/12/00361., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

H263A and SCAN1/H493R mutant TDP1 block TOP1-induced double-strand break repair during gene transcription in quiescent cells and promote cell death

  • Rubio-Contreras, Diana
  • Hidalgo-García, Daniel
  • Angulo-Jiménez, Carmen
  • Granado-Calle, Esperanza
  • Sabio-Bonilla, Margarita
  • Ruiz, José F.
  • Gómez-Herreros, Fernando
DNA single-strand break (SSB) repair defects lead to hereditary neurological syndromes. Spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1), is caused by the homozygous H493R mutation in tyrosyl-DNA phosphodiesterase 1 (TDP1), an enzyme that initiates the repair of DNA topoisomerase 1 (TOP1)-induced SSBs by unlinking the TOP1 peptide from the break. Although TDP1 also initiates the repair of TOP1-induced DNA double-strand breaks (DSBs) associated with transcription, the role of TOP1-induced DSBs in SCAN1 pathology remains unclear. Here, we have addressed the impact of the SCAN1/H493R mutation on the repair of TOP1-induced DSBs. We demonstrate that while TDP1 loss delays the repair of these breaks, SCAN1/H493R completely blocks it in RPE-1 quiescent cells. This blockage is specific to DSBs and is accompanied by a prolonged trapping of mutated TDP1 on DNA, but not of TOP1 cleavage complexes (TOP1cc). Intriguingly, the H263A inactivating mutation of TDP1, which accumulates TOP1cc, also blocks TOP1-induced DSB repair. Importantly, both SCAN1/H493R and H263A mutations exhibit genome instability and cell death. Moreover, we demonstrate that tyrosyl-DNA phosphodiesterase 2 (TDP2) can compensate for TDP1 loss in RPE-1 quiescent cells. Collectively, our data support the potential role of TOP1-induced DSBs as a main contributor to certain hereditary neurological syndromes. Similar content being viewed by others, This publication is part of the project PID2022-137143NB-I00 funded by MICIU/AEI/10.13039/501100011033/FEDER, UE to F.G.-H. Funding for open access charge: PID2022-137143NB-I00 funded by MICIU/AEI/10.13039/501100011033/FEDER, UE to F.G-H. D.R.-C. was recipient of a predoctoral fellowship from University of Sevilla. D.H-G. is a recipient of a predoctoral fellowship from Spanish Ministerio de Ciencia, Innovación y Universidades (FPU22/00416). C.A.-J. is a recipient of a predoctoral fellowship from Consejería de Transformación Económica, Industria, Conocimiento y Universidades of Junta de Andalucía (PAIDI2020, PREDOC_00922). M.S.-B. was recipient of a contract from University of Sevilla. We thank Keith W. Caldecott for the critical reading of the manuscript. We thank Iván V. Rosado, Daniel Gómez-Cabello, Sebastián Chávez and Jesús de la Cruz laboratories for discussion., Peer reviewed